Evidence map›Paper›PMID 36476234›Full record

ArticleBioData mining2022

Classification of breast cancer recurrence based on imputed data: a simulation study.

Rahibu A Abassi, Amina S Msengwa

Abstract read
In one paragraph

Article in BioData mining, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rahibu A AbassiDepartment of Natural Sciences, State University of Zanzibar, Zanzibar, Tanzania. rahibuabassi@yahoo.com.
Amina S MsengwaDepartment of Statistics, University of Dar es Salaam, Dar es Salaam, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have been conducted to classify various real life events but few are in medical fields; particularly about breast recurrence under statistical techniques. To our knowledge, there is no reported comparison of statistical classification accuracy and classifiers' discriminative ability on breast cancer recurrence in presence of imputed missing data. Therefore, this article aims to fill this analysis gap by comparing the performance of binary classifiers (logistic regression, linear and quadratic discriminant analysis) using several datasets resulted from imputation process using various simulation conditions. Our study aids the knowledge about how classifiers' accuracy and discriminative ability in classifying a binary outcome variable are affected by the presence of imputed numerical missing data. We simulated incomplete datasets with 15, 30, 45 and 60% of missingness under Missing At Random (MAR) and Missing Completely At Random (MCAR) mechanisms. Mean imputation, hot deck, k-nearest neighbour, multiple imputations via chained equation, expected-maximisation, and predictive mean matching were used to impute incomplete datasets. For each classifier, correct classification accuracy and area under the Receiver Operating Characteristic (ROC) curves under MAR and MCAR mechanisms were compared. The linear discriminant classifier attained the highest classification accuracy (73.9%) based on mean-imputed data at 45% of missing data under MCAR mechanism. As a classifier, the logistic regression based on predictive mean matching imputed-data yields the greatest areas under ROC curves (0.6418) at 30% missingness while k-nearest neighbour tops the value (0.6428) at 60% of missing data under MCAR mechanism.

Indexed as

Classification accuracyImputed dataMissing data mechanismsMissingness percentagesSimulation

Identifiers

PMID36476234
PMCPMC9727846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.